Moderate

Small intestinal bacterial overgrowth (SIBO)

SIBO · Gastroenterology
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Excess/abnormal bacteria in the small bowel causing bloating, flatulence, diarrhoea and malabsorption, typically arising when protective mechanisms (motility, acid, valve, anatomy) are impaired.

Red flags

  • Significant weight loss and malnutrition
  • Steatorrhoea with fat-soluble vitamin deficiency
  • B12 deficiency with neurological signs
  • Features of underlying Crohn's or malignancy

Assessment

Differential diagnosis

  • Irritable bowel syndrome
  • Coeliac disease
  • Pancreatic exocrine insufficiency
  • Carbohydrate intolerance (lactose/fructose)
  • Bile acid diarrhoea
  • Crohn's disease
  • Dysmotility (scleroderma, diabetes)

Investigations

  • Hydrogen/methane breath test (glucose or lactulose)
  • Exclude coeliac disease, exocrine insufficiency, IBD as mimics/causes
  • B12 (low), folate (often high), ferritin, fat-soluble vitamins
  • Small-bowel imaging if anatomical cause suspected (strictures, diverticula, blind loop)
  • Consider small-bowel aspirate culture (gold standard, rarely used)

Management

  • Identify predisposing factors: dysmotility, prior surgery (blind loop), strictures, diverticula, PPI use, immunodeficiency
  • Confirm with breath testing or treat empirically where pre-test probability is high
  • Correct reversible predisposers and nutritional deficiencies
  • Give a course of antibiotics — rifaximin for hydrogen-predominant SIBO
  • For methane-predominant (intestinal methanogen overgrowth) add neomycin or metronidazole
  • Replace deficiencies: B12, fat-soluble vitamins, iron
  • Optimise gut motility (prokinetic at night) where dysmotility underlies relapse
  • Address underlying disease (treat Crohn's, manage diabetic/scleroderma dysmotility)
  • Advise a reasonable diet; consider dietitian review rather than prolonged restriction
  • Reassess symptoms; re-treat or rotate antibiotics for recurrence
  • Avoid unnecessary long-term acid suppression that perpetuates overgrowth

Drugs & doses

Rifaximin 550 mg PO three times daily for 14 days
Neomycin 500 mg PO twice daily for 10–14 days (methane-predominant)
Metronidazole 400 mg PO three times daily for 7–14 days (alternative)
Low-dose erythromycin 50 mg PO at night (prokinetic for recurrence)

Disposition

Outpatient GI management with dietitian; investigate and treat the predisposing condition.

Complications & pitfalls

  • Malabsorption and weight loss
  • B12 and fat-soluble vitamin deficiency
  • Recurrent/refractory overgrowth
  • Antibiotic-associated C. difficile colitis

Exam pearls

  • SIBO frequently recurs — address the underlying cause rather than repeatedly treating symptoms
  • High folate with low B12 is a classic biochemical clue
  • Breath tests have limited sensitivity/specificity; clinical context is key
  • Chronic PPI use is a modifiable risk factor

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.